Raiss Jalali G A, Fazelzadeh A, Mehdizadeh A R
Shiraz Organ Transplant Ward, Nemazee Hospital, Shiraz, Iran.
Transplant Proc. 2007 May;39(4):941-2. doi: 10.1016/j.transproceed.2007.03.057.
Hypertension significantly increases the risk for chronic graft loss and accelerates the deterioration of transplanted kidney function. Aggressive control of blood pressure (BP) is recommended in the posttransplant period when maintenance levels of immunosuppressive drugs are achieved. The aim of this study was to investigate whether the improved control improved the graft survival.
We compared transplant kidney function in two groups of hypertensive patients matched for age, gender, donor-recipient relation, primary disease, early posttransplant course, and immunosuppressant and hypertensive therapy during 3 years follow-up. The patients were divided into satisfactory and unsatisfactory controlled blood pressure. Group 1 consisted of 98 patients with satisfactory BP control (arterial pressure <160/90 mmHg) and group 2, 98 patients with unsatisfactory BP control.
The mean through levels of cyclosporine in whole blood were similar in both groups and did not exceed 185 ng/mL. A slow but significant increase in mean creatinine levels was observed among group 2 during 3 years follow-up, whereas, among group 1, graft function remained stable. Cardiovascular events were observed only in group 2: stroke in one patient and death because of heart failure in one patient. Factors which correlated with development of post transplant hypertension were age, gender, duration of disease before transplant, and underlying disease.
Lowering BP, even several years posttransplantation, was associated with improved graft and patient survival in renal transplant recipients.
高血压显著增加慢性移植物丢失风险,并加速移植肾功能恶化。在达到免疫抑制药物维持水平的移植后期,建议积极控制血压(BP)。本研究的目的是调查更好的血压控制是否能提高移植物存活率。
我们比较了两组高血压患者的移植肾功能,这两组患者在年龄、性别、供受者关系、原发疾病、移植后早期病程以及免疫抑制剂和高血压治疗方面相匹配,随访3年。患者被分为血压控制满意组和不满意组。第1组由98例血压控制满意(动脉压<160/90 mmHg)的患者组成,第2组由98例血压控制不满意的患者组成。
两组全血中环孢素的平均血药浓度相似,均未超过185 ng/mL。在3年随访期间,第2组患者的平均肌酐水平缓慢但显著升高,而第1组的移植物功能保持稳定。心血管事件仅在第2组中观察到:1例患者发生中风;另1例患者因心力衰竭死亡。与移植后高血压发生相关的因素有年龄、性别、移植前疾病持续时间和基础疾病。
即使在移植后数年,降低血压也与肾移植受者移植物和患者存活率的提高相关。